Hansoh Pharmaceutical Group Company Limited (3692.HK)
HKD 18.5
(0.11%)
HKD 18.5
(0.11%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 4.3 Billion CNY | -1.69% |
| 2022 | 4.37 Billion CNY | 14.37% |
| 2021 | 3.82 Billion CNY | 4027.14% |
| 2020 | 92.74 Million CNY | 882.93% |
| 2019 | 9.43 Million CNY | 0.0% |
| 2018 | - CNY | 0.0% |
| 2017 | - CNY | 0.0% |
| 2016 | - CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 40.25 Million CNY | 0.0% |
| 2023 Q2 | 4.55 Billion CNY | 0.0% |
| 2023 Q4 | 4.3 Billion CNY | 0.0% |
| 2023 FY | 4.3 Billion CNY | -1.69% |
| 2022 Q4 | 4.37 Billion CNY | 0.0% |
| 2022 FY | 4.37 Billion CNY | 14.37% |
| 2022 Q2 | 4.13 Billion CNY | 0.0% |
| 2021 Q4 | 3.82 Billion CNY | 0.0% |
| 2021 FY | 3.82 Billion CNY | 4027.14% |
| 2021 Q2 | 3.86 Billion CNY | 0.0% |
| 2020 FY | 92.74 Million CNY | 882.93% |
| 2020 Q4 | 92.74 Million CNY | 0.0% |
| 2020 Q2 | 25.73 Million CNY | 0.0% |
| 2019 FY | 9.43 Million CNY | 0.0% |
| 2019 Q4 | 9.43 Million CNY | 0.0% |
| 2019 Q2 | 10.36 Million CNY | 0.0% |
| 2018 FY | - CNY | 0.0% |
| 2018 Q3 | - CNY | 0.0% |
| 2018 Q4 | - CNY | 0.0% |
| 2017 FY | - CNY | 0.0% |
| 2016 FY | - CNY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 6.8 Million HKD | -63097.293% |
| Grand Pharmaceutical Group Limited | 3.4 Billion HKD | -26.423% |
| Extrawell Pharmaceutical Holdings Limited | 120.41 Million HKD | -3474.234% |
| Wai Yuen Tong Medicine Holdings Limited | 460.94 Million HKD | -833.668% |
| Qianhai Health Holdings Limited | 487 Thousand HKD | -883623.819% |
| Lee's Pharmaceutical Holdings Limited | 204.14 Million HKD | -2008.227% |
| Essex Bio-Technology Limited | 294.02 Million HKD | -1363.745% |
| Tongfang Kontafarma Holdings Limited | 333.82 Million HKD | -1189.227% |
| PuraPharm Corporation Limited | 424.77 Million HKD | -913.192% |
| SSY Group Limited | 3.37 Billion HKD | -27.553% |
| JBM (Healthcare) Limited | 133.4 Million HKD | -3126.019% |
| Jacobson Pharma Corporation Limited | 749.37 Million HKD | -474.307% |
| China Resources Pharmaceutical Group Limited | 85.84 Billion HKD | 94.987% |